For a copy of your registration receipt, please log into your registration record and proceed until you get to the registration confirmation page to retrieve a copy of your registration receipt. Click HERE and click “Modify Registration” and enter your email address and reference number.

We only offer a fillable invoice. The invoice is for your use only, and we do not need a copy. Click HERE for the invoice.

The FedEx Office Print & Ship Center: https://local.fedex.com/en-us/wa/seattle/office-5161, which is located at the Arch Building of the Seattle Convention Center (approximately 3 blocks away from the CROI poster presentation area), and their phone number is (206) 467-1767.

Note: they are closed on Saturday and Sundays, therefore you should place your order(s) the week prior. Additionally, anticipate a 24-hour turnaround time for processing.

Before the submission deadline, the submitter may log in and edit coauthor details from within the abstract. After the submission deadline, contact CROIabstracts@iasusa.org for corrections to the author’s information.

CROI profiles for the abstract submission system reset each year to ensure that updated information is obtained for authors and coauthors of abstracts. You will need to create a new account in the abstract submission system.

The submitting author can make changes to the abstract submission by editing the author’s information within the abstract. See Abstract Guidelines and Submission for more information and to access the abstract system.

Your name and contact information on your CROI profile appear as it was entered when your profile was created by you. You may update your profile within the abstract system. See Abstract Guidelines and Submission for more information and to access the abstract system.

The abstract submitter provided the institution information for each author listed in the abstract submission. The submitter may correct the entry prior to the submission deadline. After the submission deadline, contact CROIabstracts@iasusa.org for corrections to the author’s information. See Abstract Guidelines and Submission for more information and to access the abstract system.

For technical assistance with the abstract submission site, email Support@cadmiumcd.com For assistance with abstract content or other questions about CROI, email CROIabstracts@iasusa.org or call 415-544-9400 between 8:30 AM to 5:30 PM PT. Will I receive a confirmation email notifying me that my abstract submission was complete?

Upon submission, a confirmation email is sent to the abstract submitter. All coauthors listed on the abstract are copied on the confirmation email. Confirmation emails are sent from CROIabstracts@iasusa.org. If you have not received the email, please check your spam folder and add CROIabstracts@iasusa.org to your safe sender list.

Common reasons for declining an abstract include the following:

• Subject matter is not appropriate for CROI
• Information is not new enough
• Abstract duplicates other submissions
• Data are not included or offer inadequate/insufficient support for conclusions
• Statistical evaluation is absent or inadequate
• Format does not follow guidelines (eg, section[s] missing, more than 1 graphic, table, or figure submitted)
• Submission is poorly written overall
• Background does not summarize the hypothesis
• Methodology is inadequate or insufficient to support conclusions
• Controls are absent or inadequate
• Summary of essential results is absent or inadequate
• Submission reports clinical trial data from unplanned analysis or incomplete or ongoing studies

Abstract submissions need to describe the precise findings of the study; promise of results “to be determined” or trials in progress are not acceptable. For more information, visit the Abstract Guidelines and Submission page.

Once the submission process ends, abstracts immediately enter the peer review and scoring process. Therefore, no changes can be made after the submission deadline, unless changes or clarification are specifically requested by the abstract review team. Updates and new data can be included in the presentation at CROI.

The contents of CROI conference materials are protected by copyright. Permission to replicate or reproduce any part of a CROI abstract must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data, figures, and presentation slides from a CROI abstract belong to the abstract author(s) and study sponsors as relevant. For more information, please submit a permission request form or email CROIinfo@iasusa.org.

Visit Abstract Guidelines and Submission for information on copyright for abstracts submitted to CROI. Visit Embargo Policies And Press Release Policies for information on the embargo and public release of abstracts presented at CROI.

Yes, it is the responsibility of the abstract submitter to ensure that all coauthors have reviewed and approved the content of the abstract and their inclusion in the list of authors before the abstract is submitted. See the Abstract Guidelines page for more information.

The submission deadline depends on the subject matter of the abstract (eg, general or late-breaking research on HIV and hepatitis viruses and their related conditions related conditions, or emerging infections such as SARS-CoV-2 or monkeypox virus. Visit the Important Dates and Deadlines page for the details on the varying submission deadlines for CROI.

The CROI Abstract eBook is released to registered attendees on or around the first day of the conference. Abstracts are released to the public on the CROI website after they are presented at the Conference. For updates on the public release of abstracts, please visit the CROI website.

If exigent circumstances prevent the designated presenting author from attending the conference in person, a coauthor or colleague must be appointed to present the abstract in person at CROI.

Please contact CROIabstracts@iasusa.org as soon as possible. If the new presenter is a coauthor, please provide their name. If the new presenter is a colleague, please provide their name, institution, city, country, and email address. The new presenter must register to attend CROI in person, and disclose financial relationships with ineligible companies.

Abstract submissions need to describe the precise findings of the study; promise of results “to be determined” or trials in progress are not acceptable. For more information, visit the Abstract Guidelines and Submission page.

In general, CROI does not accept work that has been previously published or publicly presented, or that is scheduled to be published or presented prior to CROI. Consideration may be given to a previously presented submission if meaningful newer data or different analyses are included, or if the prior or anticipated presentation was or will be at a conference not focused on HIV-, viral hepatitis, or SARS-CoV-2-related topics. Electronic publication ahead of print that has been peer-reviewed and made generally accessible to the public is considered publication. However, if the authors provide an explanation of new data that will be presented at CROI beyond the prepublication, the abstract will be considered for presentation. For more information, visit the Abstract Guidelines and Submission webpage.

No, you do not need to update your password every time you edit your submission profile. You can proceed to save changes to your submission profile without refilling out the password section.

The application submission is now open. Please click here to apply.

An Affiliated and Proximate Activity is any activity, event, or meeting, including virtual meetings and conference calls that have been approved, held at any time from 3 days before (Thursday, February 16) through 2 days after (Friday, February 24) CROI 2023, and targeted toward including any REGISTRANTS of CROI.